Drug intelligence / Profile preview

AuNP-BBN-Pt3

Development stage
Preclinical
Lead developer
Universidade de Lisboa
Modality
Nanoparticles → Drug Delivery Systems, Peptides, Small Molecules
Administration
Intraperitoneal
01

Overview

**AuNP-BBN-Pt3** is an experimental, GRPR-targeted gold-nanoparticle nanotherapeutic designed for prostate cancer theranostics. It comprises a small gold nanoparticle core functionalized with a thiolated DOTA derivative, the bombesin-derived GRPR-targeting peptide BBN[7-14], and a Pt(IV) platinum prodrug connected through a PEGylated linker. The BBN ligand is intended to promote uptake by gastrin-releasing peptide receptor-positive tumor cells, while the Pt(IV) payload is intended to generate DNA-damaging platinum activity after cellular activation. AuNP-BBN-Pt3 was evaluated in GRPR-positive PC3 prostate cancer cells as part of a preclinical nanoparticle series; it has not been reported as a clinical drug product. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9760368/))

Other names
AuNP-BBN-Pt3AuNP-BBN-Pt-3AuNP-BBN-Pt 3
02

Targets

GRPR (Gastrin-releasing peptide receptor)DNA

Beyond the preview

Go deeper on AuNP-BBN-Pt3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AuNP-BBN-Pt3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call